August 4, 2015
Fuji Pharma announced on July 31 that the company will take over the marketing rights for three imaging agents from Guerbet Japan. The three products are the MRI imaging agent Magnescope (meglumine gadoterate), the imaging agent Lipiodol (ethyl ester of...read more